Collectively, our findings identify an epigenetic mode of action for BRD1 with H3K14ac-H3K9me3 in lipid metabolism, revealing BRD1 as a potential therapeutic target to affect lipid metabolism in HCC. Here, BRD1 is linked to hepatocellular carcinoma.